Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Three-dimensional Measurements of Diabetic Foot Ulcers

11. März 2019 aktualisiert von: Line Bisgaard Jørgensen, Odense University Hospital

Three-dimensional Measurements for Monitoring Wound Healing of Diabetic Foot Ulcers

Diabetic foot ulcers constitute an increasing health problem in Denmark concurrent with an ageing population and an increase in diabetes prevalence. Diabetic foot ulcers belong to the most serious and costly complications. Several studies have found that the size and depth of the ulcer is one of the major etiologic factors for delayed healing. Wound measurement is important in the monitoring of the wound healing process. For the last decade different 3D (three-dimensional) techniques for measuring wounds have been proposed in order to measure wound volume, but none of the technologies have been widely used. A 3D Wound Assessment Monitor (WAM) camera has been developed, which is able to measure wound size in 3D and to assess wound characteristics.

The investigators hypothesize that three-dimensional measurements of diabetic foot ulcers are feasible in the assessment of wound healing. A prospective cohort study is conducted in which newly admitted patients with a diabetic foot ulcer are included at the first visit at the multidisciplinary clinic. The patients are followed for one year or until complete wound healing, amputation or death. The four wound measurements: 2D area, 3D area, perimeter and volume are measured using the 3D-WAM camera with frequent intervals. Patient anthropometrics and wound data are collected during the study and correlated to the wound healing.

Studienübersicht

Detaillierte Beschreibung

Method

Newly admitted patients with a diabetic foot ulcer are included at the first visit in the multidisciplinary clinic. The data mentioned below are collected at the first visit and the following examinations are performed including 3D photos. The wound size (2D area, 3D area, perimeter and volume) are estimated from the photos using the 3D-WAM camera. The wound examination is repeated after 2, 4, 8, 12, 24, 36 and 52 weeks or until healing of the wound. The wound healing is estimated using changes in wound size per time unit. Patients are treated by standard ulcer treatment methods and are unaffected by the project per se. During the trial the different methods of treatment are noted including changes from initial treatment. The variables will be quantified after one year depending on time to heal, establishment of a chronic ulcer (non-healing after one year) or an amputation has been performed.

At baseline the following patient data will be collected:

  • Demographic data: gender, age
  • Smoking habits
  • Time period between onset of wound to first visit in the multidisciplinary clinic
  • Body Mass Index
  • Comorbidity using Charlson Comorbidity Index score
  • Type of diabetes, duration of diabetes
  • Diabetic complications including retinopathy, albuminuria, coronary heart diseases and neuropathy

The following examinations will be performed at baseline:

  • Blood pressure measurement
  • Peripheral blood pressure
  • Examination for neuropathy using monofilament
  • Blood samples from patients with a diabetic foot ulcer

The clinical examination of the ulcer are performed at baseline and after 2, 4, 8, 12, 24, 36 and 52 weeks or until wound healing:

  • Size of wound (2D area, 3D area, perimeter, volume) measured using the 3D-WAM camera
  • Size of wound in 2D area using the digital imaging method with the software ImageJ
  • Location of the ulcer
  • Classification of ulcer: granulation, necrosis, epithelialisation
  • Secretory potential
  • Foot deformity
  • Bone affection - if osteitis is suspected an x-ray is taken
  • Signs of infection

The different types of ulcer treatment is registered for every ulcer:

  • Type of bandage
  • Antibiotics (local, systemic)
  • Revision (method, frequency),
  • Surgery

Effect variables

  • Wound 2D area, 3D area, perimeter and volume
  • Variation in 2D and 3D area measurements during the study period
  • Percentage change in wound size after 2, 4, 8, 12, 24, 36 and 52 weeks

Endpoints

  • Wound healing
  • Amputations
  • Chronic wound (non-healing after 1 year)
  • Death

Significance

This project seeks to clarify whether 3D photos of wounds will provide accurate structural measures to illuminate the background for delayed ulcer healing, and thereby to create platform for a more evidence based treatment algorithm.

Studientyp

Beobachtungs

Einschreibung (Tatsächlich)

150

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

      • Odense, Dänemark, 5000
        • University Centre of Wound Healing, Odense University Hospital (OUH)

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

Newly admitted patients with diabetic foot ulcer to University Centre for Wound Healing, Odense University Hospital.

Beschreibung

Inclusion Criteria:

  • Newly admitted patients with diabetic foot ulcers
  • 18 years or older

Exclusion Criteria:

  • Superficial wound (less than 5x5 mm with no substantial loss of subcutaneous tissue)
  • Non-compliance (dementia, mental disorders)

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
Diabetic foot ulcers
Newly referred patients with diabetic foot ulcers from the multidisciplinary clinic: University Centre for Wound healing, Odense University Hospital, Denmark.
Three-dimensional wound measurement (2D area, 3D area, perimeter, volume) using 3D-WAM camera
Andere Namen:
  • 3D-WAM camera

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Wound healing change quantified using the 3D-WAM camera
Zeitfenster: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
The 3D wound measurements at week 2, 4, 8, 12, 24, 36 and 52 are compared to the baseline measurement at week 0.
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
Wound healing change quantified using digital imaging method
Zeitfenster: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
The 2D wound measurements at week 2, 4, 8, 12, 24, 36 and 52 are compared to the baseline measurement at week 0.
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
The variability in 2D area and 3D area measurements
Zeitfenster: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
The variability in 2D area (digital imaging method) and 3D area wound measurements (3D-WAM camera) at week 0, 2, 4, 8, 12, 24, 36 and 52 are compared
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
Diabetes type is compared to outcome of the wound
Zeitfenster: Baseline until healing, amputation or chronic wound (52 weeks)
Type 1 and 2
Baseline until healing, amputation or chronic wound (52 weeks)
Diabetes duration is compared to outcome of the wound
Zeitfenster: Baseline until healing, amputation or chronic wound (52 weeks)
In years
Baseline until healing, amputation or chronic wound (52 weeks)
BMI (kg/m2) is compared to outcome of the wound
Zeitfenster: Baseline until healing, amputation or chronic wound (52 weeks)
kg/m2
Baseline until healing, amputation or chronic wound (52 weeks)
Charlson index score is compared to outcome of the wound
Zeitfenster: Baseline until healing, amputation or chronic wound (52 weeks)
In groups
Baseline until healing, amputation or chronic wound (52 weeks)
HbA1c is compared to outcome of the wound
Zeitfenster: Baseline until healing, amputation or chronic wound (52 weeks)
mmol/mol
Baseline until healing, amputation or chronic wound (52 weeks)
Ischemia is compared to outcome of the wound
Zeitfenster: Baseline until healing, amputation or chronic wound (52 weeks)
Ischemia is defined by ankle pressure below 70 mmHg and/or toe pressure below 45 mmHg
Baseline until healing, amputation or chronic wound (52 weeks)
Neuropathy is compared to outcome of the wound
Zeitfenster: Baseline until healing, amputation or chronic wound (52 weeks)
Neuropathy is measured by Semmes Weinstein monofilament examination
Baseline until healing, amputation or chronic wound (52 weeks)
Wound duration is compared to outcome of the wound
Zeitfenster: Baseline until healing, amputation or chronic wound (52 weeks)
In weeks
Baseline until healing, amputation or chronic wound (52 weeks)

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Quality of life (Questionaires) using 36-Item Short Form Survey (SF-36) is compared to outcome of the wound
Zeitfenster: Baseline, 24 and 52 weeks
The higher the score the less disability
Baseline, 24 and 52 weeks

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Knud Yderstræde, MD, PhD, Department of Endocrinology, Odense University Hospital

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. August 2015

Primärer Abschluss (Tatsächlich)

1. Dezember 2018

Studienabschluss (Tatsächlich)

1. Dezember 2018

Studienanmeldedaten

Zuerst eingereicht

15. April 2015

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

19. April 2015

Zuerst gepostet (Schätzen)

22. April 2015

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

13. März 2019

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

11. März 2019

Zuletzt verifiziert

1. März 2019

Mehr Informationen

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Diabetes mellitus, Typ 2

Abonnieren